CRISPR Therapeutics Financials
| C2RS34 Stock | 31.28 0.19 0.61% |
CRISPR |
Please note, the presentation of CRISPR Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CRISPR Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of CRISPR Therapeutics' management manipulating its earnings.
CRISPR Therapeutics Thematic Clasifications
CRISPR Therapeutics AG is part of ISP investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Internet Service Providers. Internet Service Providers (ISP) companies and IT providers specializing in internet technologies
This theme covers Internet Service Providers. Internet Service Providers (ISP) companies and IT providers specializing in internet technologies. Get More Thematic Ideas
| ISP | View |
CRISPR Therapeutics January 23, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CRISPR Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CRISPR Therapeutics AG. We use our internally-developed statistical techniques to arrive at the intrinsic value of CRISPR Therapeutics AG based on widely used predictive technical indicators. In general, we focus on analyzing CRISPR Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CRISPR Therapeutics's daily price indicators and compare them against related drivers.
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 18.2 | |||
| Value At Risk | (6.31) | |||
| Potential Upside | 6.38 |
Complementary Tools for CRISPR Stock analysis
When running CRISPR Therapeutics' price analysis, check to measure CRISPR Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CRISPR Therapeutics is operating at the current time. Most of CRISPR Therapeutics' value examination focuses on studying past and present price action to predict the probability of CRISPR Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CRISPR Therapeutics' price. Additionally, you may evaluate how the addition of CRISPR Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |